Q BioMed Inc
OTC:QBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q BioMed Inc
OTC:QBIO
|
US |
Balance Sheet
Balance Sheet Decomposition
Q BioMed Inc
Q BioMed Inc
Balance Sheet
Q BioMed Inc
| Nov-2013 | Nov-2014 | Nov-2015 | Nov-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Nov-2020 | Nov-2021 | Nov-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
1
|
3
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
1
|
1
|
3
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
1
|
1
|
3
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Total Assets |
0
N/A
|
0
-67%
|
0
+1 200%
|
1
+1 031%
|
1
-44%
|
3
+286%
|
1
-80%
|
1
-3%
|
1
+31%
|
4
+335%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
3
|
4
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
3
|
0
|
0
|
5
|
2
|
5
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
N/A
|
4
+800%
|
0
-87%
|
3
+602%
|
6
+72%
|
2
-70%
|
5
+223%
|
8
+48%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
6
|
5
|
|
| Retained Earnings |
0
|
0
|
1
|
8
|
23
|
32
|
42
|
56
|
64
|
66
|
|
| Additional Paid In Capital |
0
|
0
|
1
|
6
|
23
|
32
|
37
|
48
|
53
|
56
|
|
| Total Equity |
0
N/A
|
0
-50%
|
0
N/A
|
2
-685%
|
0
N/A
|
0
N/A
|
5
-4 491%
|
1
+79%
|
5
-334%
|
5
+1%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-67%
|
0
+1 200%
|
1
+1 031%
|
1
-44%
|
3
+286%
|
1
-80%
|
1
-3%
|
1
+31%
|
4
+335%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
9
|
9
|
12
|
14
|
20
|
24
|
29
|
84
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|